Stock data
Structure Therapeutics Inc. (GPCR)
Structure Therapeutics Inc. (GPCR) reported net income of -US$141.20M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$176.56M | -US$141.20M | — |
| 2024 | — | — | -US$158.23M | -US$122.53M | — |
| 2023 | — | — | -US$102.78M | -US$89.62M | — |
| 2022 | — | — | -US$52.56M | -US$51.32M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$106.16M | — |
| 2026-03-31 | — | -US$75.97M | — |
| 2025-12-31 | — | US$33.00M | — |
| 2025-09-30 | — | -US$65.71M | — |
| 2025-06-30 | — | -US$61.66M | — |
| 2025-03-31 | — | -US$46.83M | — |
| 2024-12-31 | — | -US$36.48M | — |
| 2024-09-30 | — | -US$33.98M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.